Paper21836632
Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.
Harvey TJ and 7 others. Cancer Gene Ther, 2011. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo. Papers, record 21836632. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21836632
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenoviridae | Major topic |
| Genetic Therapy | Major topic |
| Hypoxia-Inducible Factor 1 | Major topic |
| Nitroreductases | Major topic |
| Prodrugs | Major topic |
| Thymidine Kinase | Major topic |
| Animals | |
| Cell Hypoxia | |
| Cell Line, Tumor | |
| Female | |
| Genetic Vectors | |
| HCT116 Cells | |
| HEK293 Cells | |
| Humans | |
| Immunohistochemistry | |
| Mice | |
| Mice, Inbred BALB C | |
| Simplexvirus | |
| Transfection | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Cancer Research UK | United Kingdom | PubMed |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16390278 | Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954. | Hum Gene Ther | 2005 | https://conductscience.org/library/papers/16390278 | PubMed |
| 2 | 10842200 | Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase. | Int J Cancer | 2000 | https://conductscience.org/library/papers/10842200 | PubMed |
| 3 | 10740254 | Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. | Mol Med Today | 2000 | https://conductscience.org/library/papers/10740254 | PubMed |
| 4 | 20539322 | Role of cell surface molecules and autologous ascitic fluid in determining efficiency of adenoviral transduction of ovarian cancer cells. | Cancer Gene Ther | 2010 | https://conductscience.org/library/papers/20539322 | PubMed |
| 5 | 17327829 | Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy. | Mol Ther | 2007 | https://conductscience.org/library/papers/17327829 | PubMed |
| 6 | 17440684 | Hypoxia in cancer: significance and impact on clinical outcome. | Cancer Metastasis Rev | 2007 | https://conductscience.org/library/papers/17440684 | PubMed |
| 7 | 17523848 | Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards. | Radiat Res | 2007 | https://conductscience.org/library/papers/17523848 | PubMed |
| 8 | 15850924 | Dual responsive promoters to target therapeutic gene expression to radiation-resistant hypoxic tumor cells. | Int J Radiat Oncol Biol Phys | 2005 | https://conductscience.org/library/papers/15850924 | PubMed |
| 9 | 12820431 | Combretastatin A-1 phosphate potentiates the antitumour activity of cisplatin in a murine adenocarcinoma model. | Anticancer Res | 2003 | https://conductscience.org/library/papers/12820431 | PubMed |
| 10 | 10455425 | Insulation of a conditionally expressed transgene in an adenoviral vector. | Gene Ther | 1999 | https://conductscience.org/library/papers/10455425 | PubMed |
| 11 | 11241346 | Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives. | J Cell Physiol | 2001 | https://conductscience.org/library/papers/11241346 | PubMed |
| 12 | 12239150 | Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy. | Blood | 2002 | https://conductscience.org/library/papers/12239150 | PubMed |
| 13 | 18225594 | Evaluation of hypoxia-mediated growth factors in a novel bladder cancer animal model. | Anticancer Res | 2007 | https://conductscience.org/library/papers/18225594 | PubMed |
| 14 | 19367257 | A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]. | Mol Ther | 2009 | https://conductscience.org/library/papers/19367257 | PubMed |
| 15 | 17485316 | Targeting tumors with hypoxia-activated cytotoxins. | Front Biosci | 2007 | https://conductscience.org/library/papers/17485316 | PubMed |
| 16 | 8986436 | Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter. | Gene Ther | 1996 | https://conductscience.org/library/papers/8986436 | PubMed |
| 17 | 16391801 | Delivery of the bacterial nitroreductase gene into endothelial cells prolongs the survival of tumour-bearing mice by bystander mechanisms. | Int J Oncol | 2006 | https://conductscience.org/library/papers/16391801 | PubMed |
| 18 | 19328781 | Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model. | Exp Eye Res | 2009 | https://conductscience.org/library/papers/19328781 | PubMed |
| 19 | 15164095 | Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector. | Gene Ther | 2004 | https://conductscience.org/library/papers/15164095 | PubMed |
| 20 | 18772902 | Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter. | Cancer Gene Ther | 2009 | https://conductscience.org/library/papers/18772902 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36717737 | Suicide gene strategies applied in ovarian cancer studies. | Cancer Gene Ther | 2023 | https://conductscience.org/library/papers/36717737 | PubMed |
| 35402634 | Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles. | Mol Ther Methods Clin Dev | 2022 | https://conductscience.org/library/papers/35402634 | PubMed |
| 28627695 | Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo. | Int J Oncol | 2017 | https://conductscience.org/library/papers/28627695 | PubMed |
| 28548065 | Gene Therapy Used in Cancer Treatment. | Biomedicines | 2014 | https://conductscience.org/library/papers/28548065 | PubMed |
| 26005859 | Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivo. | Gene Ther | 2015 | https://conductscience.org/library/papers/26005859 | PubMed |
| 25377223 | A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization. | Invest Ophthalmol Vis Sci | 2014 | https://conductscience.org/library/papers/25377223 | PubMed |
| 23542552 | The nitroreductase system of inducible targeted ablation facilitates cell-specific regenerative studies in zebrafish. | Methods | 2013 | https://conductscience.org/library/papers/23542552 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EPO | 2056 | PubTator's text mining | https://conductscience.org/library/genes/2056 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21836632
GET https://conductscience.org/api/papers/v1/21836632/references?page=2